This bill establishes a new grant program to improve real-time tracking of opioid overdoses and reversal medication use. It authorizes grants for states, local governments, law enforcement coalitions, and tribes to develop mobile-friendly data tools that map locations of both fatal/nonfatal overdoses and where first responders administered reversal medication (like naloxone). The program requires these tools to work with existing systems, focus on high-overdose areas, and share data with federal, state, tribal, and local agencies. It amends the Comprehensive Opioid Abuse Grant Program to include this data collection component under Section 3021.
This bill (S 617, the OPIOIDS Act) provides federal funding to improve data collection and law enforcement response to opioid overdoses. It directly affects states, localities, and law enforcement agencies in areas with high overdose rates by authorizing grants for better toxicology testing, data linkage across systems, and training officers to identify overdoses and trace drugs. Key provisions include mandatory reporting to a national database for grant recipients, standardized reporting requirements for forensic labs, and funding for fentanyl containment equipment for first responders. The bill focuses on concrete data-sharing improvements and resource allocation, without mandating new reporting burdens for state/local labs.
HR 5573, the Combatting Fentanyl Poisonings Act of 2025, creates three federal grant programs to address fentanyl-related harms. It funds state/local law enforcement to target illegal social media sales of controlled substances (including fentanyl-laced counterfeit pills) and provides education for schools and parents about fentanyl risks. Nonprofits receive grants up to $50,000 to run public awareness campaigns, produce educational materials, and offer counseling for families affected by fentanyl deaths - though funds cannot cover most harm reduction supplies (only naloxone is permitted). The bill allocates $10 million for law enforcement programs, $3 million for awareness grants, and $2 million for officer safety equipment like fentanyl test strips and naloxone training.
This bill, known as the STOP Nitazenes Act, directs the federal government to permanently classify nitazenes and related synthetic opioids as Schedule I controlled substances, placing them in the same legal category as heroin and fentanyl. The legislation specifically targets a broad range of chemical compounds, including etonitazene and other variants, by defining them as 2-benzylbenzimidazole opioids and requiring the Attorney General to publish a list of qualifying substances. Under the bill, any nitazene substance temporarily scheduled under emergency provisions would be made permanently scheduled upon enactment, ensuring long-term federal control. The law also mandates that the Attorney General issue implementing rules within one year, allowing for immediate interim enforcement while providing opportunities for public comment before final regulations are established.
This bill reauthorizes a federal pilot program (extending it through 2030) to provide housing support for individuals recovering from substance use disorders. It requires states receiving funds to use at least $50 million annually for stable housing, including a new allowance for up to 1% of funds to purchase furniture for temporary housing. States must report annually on housing projects, resident demographics, program outcomes, and strategies for expanding recovery housing. The program directly affects states administering housing grants and individuals seeking stable housing during opioid recovery.
S 3812, the WORK to Save Lives Act, requires the Occupational Safety and Health Administration (OSHA) to issue guidance for most private employers on acquiring opioid overdose reversal medication and training employees annually, while mandating that all federal agencies (including the Veterans Health Administration) must acquire such medication and provide annual employee training. The bill directly affects federal agencies as mandatory participants and private employers (excluding the U.S. Postal Service) as recipients of non-mandatory guidance. Key provisions include a 270-day deadline for OSHA to issue these rules after the bill’s enactment. The law aims to improve workplace safety by making overdose reversal tools more accessible without imposing direct penalties on private businesses.
HR 1961, the CARE Act, requires the Department of Health and Human Services (HHS) to create an after-action program to review and improve responses to public health emergencies. This program, to be implemented within two years, mandates HHS to analyze coordination with state/local partners, logistics, infection prevention, and recovery strategies, and report findings to Congress. The bill also requires HHS to establish a risk communication strategy within one year to ensure clear, targeted messaging for at-risk populations during health emergencies. It authorizes $3.5 million for the initial implementation of these programs. The law directly affects HHS agencies and their partners, including state health departments, tribes, and non-governmental organizations involved in emergency responses.
HR 2850, the Youth Sports Facilities Act of 2025, amends the Public Works and Economic Development Act of 1965 to expand eligibility for federal grants to include youth sports facilities. It specifically requires these facilities to address sedentary lifestyles and obesity, prioritize low-income rural youth in underserved communities, and serve children lacking access to physical education spaces or living in areas with high opioid use or violence. The bill mandates that grant-funded projects must benefit highly rural communities with limited tax revenue and support economic development through youth sports infrastructure. It directly affects communities and children in rural, underserved, or high-risk areas by directing federal funding toward building or improving local sports facilities. The key mechanism is modifying existing grant criteria to prioritize these specific community needs through new eligibility requirements.
HR 1257, the OPIOIDS Act, provides federal grants to states, localities, and law enforcement agencies to improve data collection and response to opioid overdoses. It directly affects state/local governments, law enforcement, forensic labs, and medical examiners by funding training, equipment, and standardized data reporting. Key provisions include requiring grant recipients to submit overdose data to the National Forensic Laboratory Information System, mandating the DEA to develop uniform reporting standards for drug data, and adding fentanyl containment training for first responders through COPS grants. The bill focuses on enhancing data accuracy and coordination across agencies rather than directly changing drug policies or treatment access.
This bill requires first responders and community sector members to receive training on carrying and distributing fentanyl and xylazine test strips. It directs the Health and Human Services Secretary to create public frameworks for developing and evaluating these test strips, including standards for manufacturers and pathways for clinical use. The bill also mandates a two-year study on how drug checking supplies affect overdose rates, overdose deaths, and treatment engagement, with a report to Congress afterward. The law directly affects first responders, community health organizations, and test strip manufacturers by establishing new training requirements and research standards. It focuses on practical tools to detect dangerous drugs in community settings.